A radioimmunoprecipitation assay (RIPA) was used to study the serum antibody responses to individual polypeptides that developed after infection with viruses from human rotavirus subgroups I and II. Paired sera from eight children (1 to 8.5 years of age) were used in the study. Although all of the eight acute sera were negative by the complement fixation test, four of them were positive by RIPA, indicating a previous infection by rotavirus. A significant difference in the number of polypeptides immunoprecipitated was seen among the convalescent sera. The number of polypeptides immunoprecipitated was found to be related to previous infection experience. At most, ten different polypeptides were immunoprecipitated: seven structural polypeptides VPl to VP7 and three non-structural polypeptides, NSl, NS 2 and NS3. No sera immunoprecipitated VP8 or VP9. Acute sera positive by RIPA immunoprecipitated up to five polypeptides, VP1, VP2, VP3, VP4 and VP6. One of the non-structural proteins (NS2) was found to be particularly immunogenic, since antibodies to this polypeptide were detected in several convalescent sera. Among the structural proteins VP2 and VP6 were found to be the two immunodominant polypeptides which were recognized by all convalescent sera. Only three convalescent sera immunoprecipitated VP7, the major type-specific antigen responsible for inducing neutralizing antibodies. Three of four originally seronegative children with no reactivity in the convalescent sera to VP7 developed neutralizing antibodies to a single serotype. One child developed antibodies to two serotypes.
INTRODUCTION
Rotavirus infections elicit a spectrum of antibodies to virus structural components and nonstructural components, Several antigenic specificities have been associated with the group A rotavirus particle: group determinants carried by all structural proteins (Offit et al., 1983b) , subgroup-specific determinants located on VP6 (Greenberg et al., 1983b) , the major inner capsid polypeptide (Novo & Esparza, 1981) , and probably also on VP2, another inner capsid polypeptide (Taniguchi et al., 1986 ). VP7, the major polypeptide involved in neutralization (Bastardo et al., 1981) , is a constituent of the outer capsid. Haemagglutinin activity has been associated with VP3 (Greenberg et al., 1983 a) , another outer capsid polypeptide, which has also been shown to be involved in virus neutralization (Greenberg et al., 1983a : Taniguchi et al., 1985 .
Although the sequence and pattern of the immune response to individual rotavirus polypeptides may have clinical implications, to date only limited data are available concerning the viral components that induce the immune response during a naturally acquired rotavirus infection. Sera from naturally infected mice have been shown to react with capsid polypeptides of heterologous virus strains (Oflit et al., 1983a) by radioimmunoprecipitation assay (RIPA).
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Likewise, human sera have been shown to immunoprecipitate certain structural polypeptides of bovine rotavirus in a study using purified virus, labelled in vitro, as antigen (Clark et al., 1985) . The aim of the present study was to analyse the human immune response to both structural and non-structural polypeptides of naturally infecting human rotavirus.
METHODS

Sera.
Acute and convalescent sera from eight children were tested for the development of antibody response to rotavirus polypeptides after infection. The serum specimens, which are part of a previously presented study (Uhnoo et al., 1986) , were selected after virological and serological confirmation of a rotavirus infection. Four of the children were shown to have a subgroup I rotavirus infection, all with the same electropherotype. The other four children had subgroup I1 infections, represented by three different electropherotypes .
Virus and cells. Human rotavirus strain DS-1 (subgroup I, serotype 2) and strain Wa (subgroup II, serotype 1) previously characterized by R. Wyatt (NIH, Bethesda, Md., U.S.A.) were obtained from Dr B. Tufvesson (Maim6, Sweden). The two human viruses as well as simian rotavirus SA-11 (subgroup I, serotype 3) were plaquepurified twice and inoculated at low multiplicity in monolayers of foetal rhesus monkey kidney cells .
Complement fixation test (CF) . CF test was performed by the use of two units of complement and SA-11 as antigen.
Neutralization test (NT) . NT was carried out in tube cell cultures essentially as previously described (Sato et al., 1982) . Rotavirus of serotype 1 (Wa strain), serotype 2 (DS-1 strain) and serotype 3 (SA-11) were activated with 10 p.g/ml trypsin (14900 units/mg) at 37 °C for 30 min before use. Sera, in serial twofold dilutions and inactivated at 56 °C for 30 min, were mixed with an equal volume of 200 TCIDs0/0-1 ml virus dilution. The mixture was incubated at 37 °C for 1 h and 0.2 ml inoculated on duplicate tubes of MA-104 cells. After 1 h incubation at 37 °C the cells were washed twice with Eagle's MEM. One ml Eagle's MEM containing 1 ~tg/ml trypsin was added and the tubes were incubated at 37 °C for 5 days. The antibody titres were determined by inspection of c.p.e, and measuring of viral antigen production by ELISA.
Radiolabelling of intracellular rotavirus polypeptides. Confluent monolayers of MA-104 ceils in 150 cm 2 flasks (Costar) were washed once with phosphate-buffered saline and incubated with Eagle's MEM without serum 12 h before infection. The cells were infected with trypsin-activated virus at a multiplicity of 5 to 10 p.f.u./cell or mockinfected. After 1 h adsorption at 37 °C the virus inoculum was washed off with Eagle's MEM and 20 ml Eagle's MEM containing 5 ~tg/ml trypsin and 3 ~tg/ml actinomycin D was added per flask. At 6 h post-infection the medium was replaced by 20 ml/flask of methionine-free Eagle's MEM supplemented with 5 ~tg/ml trypsin and 3 ~tg/ml actinomycin D. Seven h post-infection, the medium was replaced by 12 ml/flask of Eagle's MEM containing 1/10 the normal concentration of methionine, 100 ~tCi/ml [35S]methionine, 3 gg/ml actinomycin D, and 5 p.g/ml trypsin. After 3 h labelling, cells were scraped off and pelleted by centrifugation for 1 h at 13 000 g. Cells were lysed with 5 ml 2 ~ (w/v) Triton X-100, 0-15 M-NaC1, 0"6 M-KC1, 5 mM-disodium EDTA, 3 mM-phenylmethylsulphonyl fluoride (PMSF), 1% trasylol aprotinin and 2.5 mM-iodoacetamide in 0"01 M-Tris-HC1 pH 7.8 (RIPA buffer). The cell lysates were held on ice for 30 min and centrifuged at 30000 g for 30 min. Supernatants were collected and stored at -20 °C until used.
RIPA. This was performed as follows: mixtures of 20 ~tl of each serum dilution, 50/~1 radiolabelled cell lysate and 450 gl RIPA buffer were prepared and incubated overnight on ice. One-hundred ~tl Staphylococcus aureus Protein A-Sepharose CL-4B beads in 0.01 M-Tris-HC1, 0.15 M-NaCI, pH 8.0 was added to this mixture and incubated on ice for 1 h with frequent vortexing. The beads were centrifuged for 3 min at 10000g and washed five times with RIPA buffer and once with 0.01 M-Tris-HCI, 0.15 M-NaC1, pH 8.0. After drying at 37 °C, the immune complexes were dissociated by addition of 100 p.l sample buffer [3~ SDS, 3% 2-mercaptoethanol, 0.1% EDTA, 10% (v/v) glycerol in 62 mM-Tris-H3PO4 pH 6.8] and incubation at 100 °C for 2 min.
SDS-polyacrvlamide gel electrophoresis (SDS-PAGE).
Samples were analysed in SDS-PAGE using the discontinuous Tris-glycine buffer system of Laemmli (1970) . The spacer gel consisted of 4-5 ~ (w/v) acrylamide and 0.12~ (w/v) N,N-methylenebisacrylamide (bis) and the separation gel (14 cm) consisted of 11~ (w/v) acrylamide and 0.29 ~ (w/v) bis. N,N,N',N'-Tetramethylethylenediamine and ammonium persulphate were used for polymerization at a final concentration of 0.05 ~ of each. Polypeptides were separated in the gel at 50 V at room temperature. Gels were fixed in a solution of 10~ (v/v) glacial acetic acid and 30~ (v/v) methanol, processed for fluorography (Bonner & Laskey, 1974) using 'Enlightening', dried and exposed to Kodak X-Omat AR-5 films at -70 °C.
Chemicals and isotopes.
Protein A-Sepharose CL-4B beads were obtained from Pharmacia. Actinomycin D, PMSF, trasylol aprotinin and iodoacetamide were all purchased from Sigma. Trypsin type IX was a product of Sigma. The ~4C-methylated protein phosphorylase b (97000), bovine serum albumin (69000), ovalbumin (46000), carbonic anhydrase (30 000), lactoglobulin (18 400) Rodger et al. (1975) and Estes et al. (1983) . Note that VP5 and NS1 were not recognized.
RESULTS
The serum antibody responses to polypeptides of human rotavirus subgroups I and II were investigated by R I P A in eight human serum pairs. A summary of clinical and serological data on the children included in the study is given in Table 1 . Fig. 1 shows the profiles of asS-labelled polypeptides of DS-1 strain, W a strain and mock-infected cells after separation by S D S -P A G E . The mol. wt. of the virus-coded polypeptides were calculated and compared to previously reported data Offit et al., 1983 a) . The mol. wt. of the polypeptides of the W a strain were calculated to be 110000 (110K) for VP1, 94K (VP2), 88K (VP3), 83K (VP4), 61K (VP5), 56K for nonstructural protein (NSx), 41K (VP6), 37K (VP7), 34K (NS2), 33K (NS3), 28K (VP8) and 26K (VP9). For the DS-1 strain, corresponding mol. wt. were l18K (VP1), 92K .
t The results of the CF test and RIPA are expressed as antibody titres in sera.
(VP8) and 23K (VP9). VP5 and NS1 of Wa and DS-1 strains were only weakly labelled, and so the mol. wt. of these polypeptides were calculated from results of RIPA tests (see below). VP4 of the DS-1 strain migrated very close to VP3 and could therefore not be reproducibly distinguished. Only minor differences in tool. wt. were found between corresponding potypeptides of the Wa and DS-1 strains. The heavily labelled 43K cellular polypeptide (probably actin) seen in Fig. 1 indicates that the actinomycin D concentration used could not completely shut off cellular protein synthesis.
Analysis of the human immune response induced by different polypeptides of rotavirus subgroups I and H
Acute sera
All eight acute sera, collected 1 to 4 days after onset of illness, were negative by the CF test (Table 1) . However, four of the sera exhibited an antibody titre of/> 102 to viral polypeptides of both DS-I (subgroup I) and Wa (subgroup II) strains by RIPA (Table 2, 3) . The four sera (A1, A3, A4, A7) recognized VP2 and VP6 of both Wa and DS-1 strains (Fig. 2, 3 ). All four sera had a titre of/> 102 to VP6, which comprises 80 ~o of the protein mass of a single-shelled particle (Novo & Esparza, 1981) , while two sera reacted also with VP1 (Table 2, 3). A single serum immunoprecipitated VP4 of Wa strain to a titre of 102, whereas none immunoprecipitated VP5, NSz, VP7, NS2, NS3, VP8 or VP9. None of the sera reacted at 1:10 dilution with mock-infected cells, nor could any distinct difference be seen in antibody reactivity to Wa and DS-1 strains. Since some of the acute sera immunoprecipitated viral proteins, attempts were made to investigate the influence of the children's age on the serum titre and the number of polypeptides immunoprecipitated, but no correlation could be found.
Convalescent sera
From the RIPA results it was considered that none of the children produced antibodies to all viral polypeptides after infection with either a subgroup I or II rotavirus (Fig. 2, 3) . The marked difference in number and type of polypeptides immunoprecipitated appeared to be correlated to experience of a previous infection. Individual convalescent sera immunoprecipitated DS-1 and Wa rotavirus polypeptides with tool. wt. ranging from 118K (VP1) to 32K (NS3). No significant difference in reactivity of the antisera was seen between DS-1 and Wa strains (Fig. 2, 3) . Titres of convalescent sera to individual polypeptides of DS-1 and Wa strains are shown in Table 2 .
Titration of two sera is further illustrated in Fig. 4 . The two most immunogenic polypeptides, VP2 and VP6, were recognized by all convalescent sera. Likewise, VP1, VP3 and VP4 were immunoprecipitated by all convalescent sera, although to relatively low titres (Table 3) The figure is a composite from several SDS-PAGE gels. Acute sera (A) and convalescent sera (C) were examined at a 10 -2 dilution. Precipitation of VP4 refers only to the Wa strain due to difficulties in distinguishing VP4 from VP3 of the DS-1 strain• The outer capsid polypeptide VP5, a cleavage product of VP3 , and the non-structural polypeptide NSa (56K) were only immunoprecipitated by three sera (C1, C4, C7). The corresponding acute sera were positive by RIPA. The non-structural polypeptide NS 2 was found to be relatively immunogenic and antibodies to NS 2 were found in four sera (C1, C4, C5, C7) three of which had antibodies also to VP7 (Table 2 , 3). Two of the convalescent sera (C1, C7) reacted with the non-structural proteins NS3 (32K to 33K). None of the sera tested immunoprecipitated VP8 and VP9, two outer capsid polypeptides, although they were well labelled with [35S]methionine (Fig. 1) . * Antibodys titres in sera were defined as the reciprocal of the highest dilution at which a distinct band could be seen on the X-ray film after a fixed exposure time. Titres of ~ 10 have been omitted. f V P3 and VP4 could not be distinctly separated on the gel; a joint titre for both VP3 and VP4 is therefore given. { Acute sera tested at 10 -~ and 10 -2 dilution. § Convalescent sera. 10 2 10 2 10 2 10 2 > 10 2 5 X 10 2 10 * 5 X 10 3 5 × 10 3 10 2 10 2 10 5 10 2 10 3 10 2 10 3 lif t 10 3 l0 3 10 ~ * Antibody titres in sera were defined as the reciprocal of the highest dilution at which a distinct band could be seen on the X-ray film. Titres of ~< 10 have been omitted. t Acute sera tested at 10 -1 and 10 -2 dilution. { Convalescent sera.
Five convalescent sera showed no antibodies to VP7, the major neutralizing antigen, although they reacted with several other polypeptides. Four of these sera (C2, C5, C6, C8) whose corresponding acute sera were negative by RIPA (~< 10), were further examined by NT. As seen in Table 4 , three children developed a monotypic antibody response, although the titre in C2 was very low. One child developed an antibody response against serotype 3 and possibly serotype 1. RIPA.
IP
DISCUSSION
In the present study, a RIPA was used to analyse the polypeptides of human rotavirus recognized by serum antibodies acquired following a natural infection with human rotavirus subgroups I and II. Previous studies analysing the immune response in humans to different polypeptides have exclusively used antigen not derived from naturally infecting virus (Clark et al., 1985) .
All eight acute sera were found to be negative by the CF test, whereas only four sera were classified as negative (~< 10) by RIPA. Due to the discrepancies between the CF test and RIPA, an ELISA was employed and found to correlate well with the RIPA results (unpublished observations).
RIPA has a wide application for analysis of antibody specificity. While immunoblot assays use SDS-denatured antigens which favour detection of antibodies against denaturation-resistant epitopes, our RIPA used milder denaturing conditions. Although the Protein A used in RIPA does not recognize subclass 3 of human IgG, we have found RIPA to be superior to immunoblotting for characterization of the immune response to rotavirus (unpublished observations).
In our study, a significant difference in the number of polypeptides immunoprecipitated was observed among the sera analysed. The antibody titre and the number of polypeptides immunoprecipitated were found to be related to experience of previous infection. None of the acute sera positive by RIPA immunoprecipitated VP5, VP7 or any of the non-structural polypeptides. The eight convalescent sera analysed by RIPA recognized between five and ten different polypeptides with VP6, a subgroup-specific protein (Greenberg et al., 1983b ) located on the inner capsid, being the strongest immunogen. Antibodies to VP6 were detected up to a serum dilution of l0 -s. The second most effective immunogen polypeptide, VP2, which probably also carries subgroup-specific epitopes (Taniguchi et al., 1986) , was recognized by all convalescent sera and by four acute sera. It is not known whether the high antibody response to VP2 and VP6 reflects strong immunogenicity of the polypeptides, or only the fact that VP2 and VP6 comprise nearly 100~ of the single-shelled particle (Novo & Esparza, 1981) .
VP1, which has been reported to be difficult to immunoprecipitate with sera from parenterally immunized animals (Ericson et al., 1982; Offit et al., 1983 b) , was immunoprecipitated by all convalescent sera as well as by some of the antibody-positive acute sera. The different capacity of sera to react with VP1 after natural infection and parenteral immunization might be explained by the degree to which VP1 is accessible to the immune system.
All convalescent sera immunoprecipitated VP3 (Wa strain), an outer capsid protein suggested to carry serotype-specific antigen sites (Greenberg et al., 1983a; Taniguchi et al., 1985) . However, since convalescent sera from children infected with subgroup I or II rotaviruses reacted equally well with VP3, the major part of the polypeptide is probably exposing common antigenic sites. It is interesting to note that neither VP8 nor VP9, two outer capsid polypeptides Mason et al., 1983; Offit et al., 1983a; Svensson, 1984) , were immunoprecipitated by any of the sera, although they were efficiently labelled by [asS]methionine and clearly identified in virus-infected cell lysates (Fig. 1 ). An opposite phenomenon was seen with VP5 and NSt, which could not be identified in virus-infected cell lysates but which were identified by immunoprecipitation. The inability of the sera to immunoprecipitate VP8 and VP9 may be due to the low immunogenicity of these proteins or the less likely possibility that VP8 and VP9 antibodies are of IgG3 subclass or IgM and therefore do not interact with Protein A.
An interesting observation in this study was the generally low ability to detect antibody response to VP7, the major type-specific antigen, located on the outer capsid. Four originally seronegative children with no reactivity in their convalescent sera to VP7 but to VP3 by RIPA (Table 3 ) developed neutralizing antibodies detectable by NT. Three of these developed neutralizing antibodies against a single serotype. The fourth child developed a possible heterotypic antibody response. Heterotypic immunity in man has also been reported by Clark et al. (1985) . It appears from the immunoprecipitation data that the possible heterotypic immunity might be mediated by antibody to VP3, since there is no response to VP7 as seen by RIPA. However, it cannot be excluded that the RIPA employed fails to detect low levels of VP7 antibodies. Previous studies have shown that monoclonal antibodies (MAbs), specific for VP3 of rhesus rotavirus have neutralizing capacity (Greenberg et al., 1983a) , and that MAbs specific for VP3 of human rotavirus can neutralize several human rotavirus serotypes in vitro (Taniguchi et al., 1985) . MAbs directed against VP3 have also been shown to elicit protection against heterotypic rotaviruses in vivo (Offit et al., 1986) . If VP3 is antigenically more conserved than VP7, a reassortant rotavirus vaccine containing VP3 and VP7 from distinct rotavirus serotypes might induce protection against two or more serotypes.
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